Literature DB >> 16966642

Vanishing disc neovascularization following intravitreal bevacizumab (avastin) injection.

Steven M Friedlander1, Robert M Welch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966642     DOI: 10.1001/archopht.124.9.1365

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  6 in total

1.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

2.  Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab.

Authors:  Osamu Sawada; Hajime Kawamura; Masashi Kakinoki; Masahito Ohji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-26       Impact factor: 3.117

3.  Acute bacterial endophthalmitis after intravitreal bevacizumab injection: Case report and literature review.

Authors:  Saba Al Rashaed; Abdulaziz Rushood
Journal:  Saudi J Ophthalmol       Date:  2012-04-28

4.  Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels.

Authors:  Shinji Ueno; Mary Ellen Pease; Delphine M Bonnet Wersinger; Tomohiro Masuda; Stanley A Vinores; Tamar Licht; Donald J Zack; Harry Quigley; Eli Keshet; Peter A Campochiaro
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

5.  Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture.

Authors:  J Fernando Arevalo; Juan G Sanchez; Andres F Lasave; Lihteh Wu; Mauricio Maia; Sergio Bonafonte; Miguel Brito; Arturo A Alezzandrini; Natalia Restrepo; Maria H Berrocal; Mario Saravia; Michel Eid Farah; Jans Fromow-Guerra; Virgilio Morales-Canton
Journal:  J Ophthalmol       Date:  2011-03-30       Impact factor: 1.909

6.  Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye.

Authors:  Masahiko Sugimoto; Takayasu Nunome; Rie Sakamoto; Maki Kobayashi; Mineo Kondo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-28       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.